Vaccine Therapy in Metastatic Renal Cell Carcinoma: Past, Present, and Future The ASCO Post, 28 Nov 2016 If the ADAPT study replicates the results of the previous phase II study of AGS-003 plus sunitinib, this regimen will have the…